CLDI — Calidi Biotherapeutics, Inc.

CLDICalidi Biotherapeutics, Inc.

AMEX · US · Healthcare · Biotechnology · calidibio.com

0.1847USD+0.43%Mkt Cap: 3.57M USDP/E: —Last update: 2026-06-01

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatm…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap3.57M USD

Enterprise Value-985.91K USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-19.91M USD

Revenue/Share—

Last Price0.1847 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees29

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.21

PEG—

EV/EBITDA0.05

EV/Revenue—

P/S—

P/B0.36

EPS (TTM)-4.17

EPS (Forward)-0.90

52W Range

0.16000% of range19.20

52W High19.20 USD

52W Low0.1600 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-529.56%

ROA-224.75%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-21.29M USD

CapEx (TTM)120.00K USD

FCF Margin—

FCF Yield-332.33%

Net Debt-3.04M USD

Net Debt/EBITDA0.16

Balance Sheet

Debt/Equity0.68

Current Ratio1.59

Quick Ratio1.42

Book Value/Sh0.5100 USD

Cash/Share0.5070 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:12

Split DateAug 5, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.19.31M

Float10.72M

Insiders2.37%

Institutions4.53%

Short Interest

Short Ratio0.3d

Short % Float20.39%

Short % Out.19.96%

Shares Short3.04M

Short (prev mo.)244.36K

Technical

SMA 500.2331 (-20.8%)

SMA 2001.121 (-83.5%)

Beta1.38

S&P 52W Chg27.94%

Avg Vol (30d)7.81M

Avg Vol (10d)2.66M

Technical Indicators

RSI (14)39.9

MACD-0.0210

MACD Signal-0.0255

MACD Hist.+0.0046

BB Upper0.2252 USD

BB Middle0.1943 USD

BB Lower0.1635 USD

BB Width31.77%

ATR (14)0.0210 USD

Vol Ratio (20d)0.54x